Heterogeneous nuclear ribonucleoprotein A/B drives gastric cancer and epithelial-mesenchymal transition via the Akt-GSK3β-Wnt pathway
Molecular Pharmacology · 2025
DOI: 10.1016/j.molpha.2025.100066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2025. Verfasst von Luo Huiru und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Genomic Medicine, International Cooperative Laboratory of Tradi…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Stomach Neoplasms, Glycogen Synthase Kinase 3 beta, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jinan University, Guangdong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Gastric cancer (GC) is a leading cause of cancer-related deaths globally, with metastasis critically impacting prognosis. Splicing factors are key regulators of tumorigenesis, particularly in metastasis. In this exploratory study, we investigated the role and mechanism of heterogeneous nuclear ribonucleoprotein A/B (HNRNPAB) in GC cell invasion and migration. We detected a 3.45-fold increase in HNRNPAB protein levels in highly metastatic MKN45 cells compared with low metastatic MKN7 cells (P < .01) and marked upregulation in human GC tissues (n = 408) versus normal tissues (n = 211, P < .05, predicted by gene expression profiling interactive analysis). HNRNPAB overexpression in MKN45 and MKN7 cells substantially enhanced proliferation by 50% (P < .001, 3-[4,5-dimethyl-2-thiazolyl]-2,5-diphenyl-2-H-tetrazolium bromide assay), migration by 60% (P < .001, wound healing assay), and invasion by 70% (P < .001, Transwell assay), whereas knockdown reduced these by similar magnitudes. Mechanistically, HNRNPAB decreased E-cadherin (0.5 ± 0.1-fold, P < .001) and increased N-cadherin (1.8 ± 0.2-fold), Vimentin (2.0 ± 0.2-fold), and Snail levels (1.7 ± 0.2-fold, P < .001), promoting epithelial-mesenchymal transition, which was associated with Akt-GSK3β-Wnt pathway modulation by elevating phosphorylated Akt (Ser473, 2.0 ± 0.2-fold) and phosphorylated glycogen synthase kinase 3β (Ser9, 1.8 ± 0.2-fold, P < .001). These findings suggest that HNRNPAB is a potential diagnostic and therapeutic target for GC. SIGNIFICANCE STATEMENT: This exploratory study reveals that heterogeneous nuclear ribonucleoprotein A/B is associated with gastric cancer progression and epithelial-mesenchymal transition through its potential modulation of the Akt-GSK3β-Wnt signaling pathway. Targeting heterogeneous nuclear ribonucleoprotein A/B could offer novel therapeutic approaches for improving treatment outcomes in gastric cancer, highlighting its potential as a biomarker for disease prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Genomic Medicine, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development…
- International School, Jinan University, Guangzhou, China.
Förderung
- Jinan University
- Guangdong Provincial Natural Science Foundation
Zitieren
APA
Huiru, L., Traore, A. G. Y., Hu, J., Miao, Y., Yu, L., Huang, M., Guo, Z., Zheng, Q., & Wang, F. (2025). Heterogeneous nuclear ribonucleoprotein A/B drives gastric cancer and epithelial-mesenchymal transition via the Akt-GSK3β-Wnt pathway. Molecular Pharmacology. https://doi.org/10.1016/j.molpha.2025.100066
Vancouver
Huiru L, Traore AGY, Hu J, Miao Y, Yu L, Huang M, et al. Heterogeneous nuclear ribonucleoprotein A/B drives gastric cancer and epithelial-mesenchymal transition via the Akt-GSK3β-Wnt pathway. Molecular Pharmacology. 2025. doi:10.1016/j.molpha.2025.100066
BibTeX
@article{Huiru2025,
author = {Huiru, Luo and Traore, Aime Gael Yaya and Hu, Junyi and Miao, Yinshuang and Yu, Liu and Huang, Mengzhen and Guo, Zhongxue and Zheng, Qing and Wang, Feng},
title = {Heterogeneous nuclear ribonucleoprotein A/B drives gastric cancer and epithelial-mesenchymal transition via the Akt-GSK3β-Wnt pathway},
journal = {Molecular Pharmacology},
year = {2025},
doi = {10.1016/j.molpha.2025.100066}
}
EUVIMED